Nuveen Asset Management, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 116 filers reported holding REVANCE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 2.86 and the average weighting 0.6%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,922,111
-32.0%
603,497
+50.0%
0.00%
-50.0%
Q2 2023$10,184,592
+78496.9%
402,394
+0.0%
0.00%
-20.0%
Q1 2023$12,958
+40.2%
402,282
-19.7%
0.01%
+25.0%
Q4 2022$9,245
-99.9%
500,847
-19.1%
0.00%
-42.9%
Q3 2022$16,717,000
+236.8%
619,164
+72.4%
0.01%
+250.0%
Q2 2022$4,963,000
-29.8%
359,120
-3.2%
0.00%0.0%
Q1 2022$7,068,000
+15.9%
370,821
-0.8%
0.00%0.0%
Q4 2021$6,100,000
-43.1%
373,732
-2.8%
0.00%
-33.3%
Q3 2021$10,717,000
-35.6%
384,664
-31.4%
0.00%
-40.0%
Q2 2021$16,631,000
+30.4%
561,094
+23.0%
0.01%
+25.0%
Q1 2021$12,754,000
-5.5%
456,323
-4.2%
0.00%
-20.0%
Q4 2020$13,494,000
+26.0%
476,149
+11.8%
0.01%
+25.0%
Q3 2020$10,710,000
+9.4%
426,021
+6.3%
0.00%0.0%
Q2 2020$9,789,000
+88.3%
400,856
+14.1%
0.00%
+33.3%
Q1 2020$5,199,000
-2.0%
351,250
+7.5%
0.00%
+50.0%
Q4 2019$5,303,000
+32.7%
326,716
+6.3%
0.00%0.0%
Q3 2019$3,996,000
+51.5%
307,372
+51.2%
0.00%
+100.0%
Q2 2019$2,638,000203,3370.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$52,671,00026.22%
NovaQuest Capital Management, L.L.C. 1,558,426$24,561,00022.85%
Sio Capital Management, LLC 254,581$4,012,0001.08%
ArrowMark Colorado Holdings LLC 3,409,217$53,729,0000.51%
Fosun International Ltd 472,532$7,447,0000.47%
Rhenman & Partners Asset Management AB 193,181$3,045,0000.36%
Phoenix Investment Adviser LLC 4,900$77,0000.17%
HARBOURVEST PARTNERS LLC 26,565$419,0000.15%
Quinn Opportunity Partners LLC 56,672$893,0000.12%
MFN Partners Management, LP 46,000$725,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders